Management Credibility Analysis

Unavailable
Verified Management Score Unavailable
Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed
Verified Catalysts Unavailable
No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive
Not disclosed
Headquarters
5818 EL CAMINO REAL, CARLSBAD, CA
Founded
Not disclosed

📈 Company Timeline

Major business events
Positive
Negative
Neutral
5 Aug 2026

Alphatec Holdings, Inc. filed Form 10-Q

Alphatec Holdings, Inc. submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.

5 Aug 2026

Alphatec Holdings, Inc. securities registration filing

Alphatec Holdings, Inc. filed a registration or prospectus document concerning securities.

5 Aug 2026

Alphatec Holdings, Inc. reported Operating or financial results

Alphatec Holdings, Inc. filed an 8-K covering operating or financial results, supporting financial statements or exhibits.

12 Jun 2026

Alphatec Holdings, Inc. securities registration filing

Alphatec Holdings, Inc. filed a registration or prospectus document concerning securities.

12 Jun 2026

Alphatec Holdings, Inc. reported A director or senior management change or compensation event

Alphatec Holdings, Inc. filed an 8-K covering a director or senior management change or compensation event, shareholder voting results, supporting financial statements or exhibits.

Capital Structure & Financial Position

Financial strength and liquidity analysis
Cash and equivalents (USD)$118.66M
Total assets (USD)$791.03M
Shareholders' equity (USD)−$12.07M
Long-term debt (USD)$510.74M
Debt due within a year (USD)$65.01M

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated

Peer Comparison - Health Care

Company Price Market Cap
LLY - Eli Lilly and Company $1,276.13
Yahoo Finance
$1.20T
JNJ - Johnson & Johnson $256.74
Yahoo Finance
$618.71B
ABBV - AbbVie Inc. $284.80
Yahoo Finance
$503.28B
UNH - UnitedHealth Group Incorporated $418.43
Yahoo Finance
$375.58B
MRK - Merck & Co., Inc. $148.55
Yahoo Finance
$366.50B

📋 Corporate Actions

Recent and upcoming corporate events
Verified Corporate Actions Unavailable
Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis
QuarterRevenue (USD)Operating incomeNet incomeDiluted EPS (USD)Filed
Q3 2018$23.00M−$7.53M−$9.36M−$0.2210-Q · 9 Nov 2018
Q2 2018$22.04M−$6.55M−$7.08M−$0.2110-Q · 3 Aug 2018
Q1 2018$21.31M−$667,000−$1.92M−$0.0910-Q · 11 May 2018
Q4 2017$26.28M−$3.61M$9.06MUnavailable10-K · 9 Mar 2018
Q3 2017$23.10M−$1.26M−$3.14M−$0.2310-Q · 9 Nov 2017
Q2 2017$24.38M−$735,000−$2.70M−$0.2410-Q · 11 Aug 2017

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Buy
Target: $15.18
39.5% upside potential
📈
Strong Buy
Unavailable
👍
Buy
11
⏸️
Hold
0
📉
Sell
0
11 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved Targets range 12.00–24.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments
Verified Dividend Data Unavailable
Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable
Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity
5
Oct 2026
Carls Thomas Andrew
EVP, Data & Imaging Solutions
Grant or award
Unavailable per share
200,000 shares
SEC Form 4
10
Sep 2026
Miles Patrick
Director, CEO
Open-market purchase
$8.81 per share
115,000 shares
SEC Form 4
5
Aug 2026
Marshall Tyson Eliot
GENERAL COUNSEL & CORP. SEC.
Open-market sale
$9.65 per share
8,168 shares
SEC Form 4
11
Jun 2026
MCGINNIS KAREN K
Director
Open-market sale
$8.01 per share
6,050 shares
SEC Form 4
10
Jun 2026
MCGINNIS KAREN K
Director
Grant or award
Unavailable per share
32,012 shares
SEC Form 4
10
Jun 2026
Blackford Quentin S.
Director
Grant or award
Unavailable per share
32,012 shares
SEC Form 4
10
Jun 2026
Valentine Keith
Director
Grant or award
Unavailable per share
32,012 shares
SEC Form 4
10
Jun 2026
Pelizzon David R
Director
Grant or award
Unavailable per share
32,012 shares
SEC Form 4
10
Jun 2026
Demski David M
Director
Grant or award
Unavailable per share
32,012 shares
SEC Form 4

Top Shareholders

Blackrock, Inc.
11,326,677 shares
12.277% change
6/30/2026
Vanguard Group Inc
6,883,626 shares
1.006% change
12/31/2025
Braidwell Lp
6,531,439 shares
200.61% change
6/30/2026
American Century Companies Inc
6,521,659 shares
1.508% change
6/30/2026
Vanguard Capital Management Llc
5,122,681 shares
4.251% change
6/30/2026
Bnp Paribas Asset Management Holding S.A.
3,536,538 shares
-2.206% change
6/30/2026
State Street Corp
3,481,349 shares
14.852% change
6/30/2026
Jacobs Levy Equity Management, Inc
3,352,133 shares
New% change
6/30/2026
Geode Capital Management, Llc
3,188,894 shares
9.719% change
6/30/2026
Royal Bank Of Canada
2,995,410 shares
-33.68% change
6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed · 1 day ago